Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGBL5 antisense RNA 1 (AGBL5-AS1) is a long non-coding RNA gene located on chromosome 2 (reverse strand, positions 27,049,683-27,050,264, GRCh38). As an antisense non-protein coding transcript, AGBL5-AS1 is thought to regulate or interact with its corresponding sense protein-coding gene, AGBL5. However, there is currently no reported evidence of AGBL5-AS1 being implicated directly in disease or functioning as a therapeutic target. The specific physiological or pathological functions of AGBL5-AS1 in humans remain uncharacterized in the literature and databases.
None applicable (no known drugs targeting this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AGBL5 antisense RNA 1 (AGBL5-AS1).